好文档就是一把金锄头!
欢迎来到金锄头文库![会员中心]
电子文档交易市场
安卓APP | ios版本
电子文档交易市场
安卓APP | ios版本

柳叶刀投稿要求information-for-authors.pdf

7页
  • 卖家[上传人]:小**
  • 文档编号:93651906
  • 上传时间:2019-07-26
  • 文档格式:PDF
  • 文档大小:228.02KB
  • / 7 举报 版权申诉 马上下载
  • 文本预览
  • 下载提示
  • 常见问题
    • Information for Authors May 2013 How to submit your paper Manuscript submission Manuscript submission to all Lancet journals is free. Manuscripts should be submitted online via the The Lancet Oncology’s online submission and peer review website (known as EES) at • Simply log on to EES and follow the onscreen instructions for all submissions • If you have not used EES before, you will need to register first. In EES, the corresponding author is the person who enters the manuscript details and uploads the submission files • Inclusion of illustrations (photographs, graphs, diagrams, etc) is a prerequisite for publication. Submission of original and editable artwork files is encouraged. Digital photography files should have a resolution of at least 300 dpi and be at least 107 mm wide • In almost all cases, if you have a finished manuscript, you should submit it, rather than contacting The Lancet Oncology to enquire whether an unseen manuscript is likely to be accepted • Unless you have been asked by the Editor to submit by email, you should use the online system for all types of submission, including correspondence • If you have any technical problems or questions, please contact our dedicated customer support (available 24 hours a day, 365 days a year): For the Americas: +1 888 834 7287 (toll-free in USA and Canada) For Asia and Pacific: +81 3 5561 5032 For Europe and rest of the world: +353 61 709190 • Editorial queries can be sent to the Editor, Dr David Collingridge, at david.collingridge@ Covering letter • You should upload your covering letter at the “Enter Comments” stage of the online submission process • Use the covering letter to explain why your paper should be published in The Lancet Oncology rather than elsewhere • It is helpful to indicate what could shorten your paper—the full paper can be reviewed and a shorter version published; a table or figure, details of a DNA sequence, or further references, for example, can be published on our website or made avail- able from the authors Statements, permissions, and signatures Authors and contributors • All authors, and all contributors (including medical writers and editors), should specify their individual contributions at the end of the manuscript • The Lancet Oncology will not publish any paper unless we have the signatures of all authors • We suggest you use the author statement form and either upload the signed copy with your submission, or fax to +44 (0) 1865 853 017 • Please include written consent of any cited individual(s) noted in acknowledgments or personal communications • These forms should only be supplied if your paper is selected for peer review. You will receive instruction from the editorial team when to send these documents Conflicts of interest A conflict of interest exists if authors or their institutions have financial or personal relationships with other people or organisations that could inappropriately influence (bias) their actions. Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships, academic competition, or intellectual passion. A conflict can be actual or potential, and full Uniform Requirements for Manuscripts Submitted to Biomedical Journals http://download.thelancet. com/flatcontentassets/authors/ icmje.pdf COPE Code of Conduct http://publicationethics.org/ files/u2/New_Code.pdf The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties and countries. The journal publishes a range of article types that encompass all aspects of oncological medicine: Comment, Correspondence, News, Cancer and Society, Article, Review, Historical Review, Health-care Development, and Personal View. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published within 8 weeks from submission. All accepted Articles will be published online first before appearing in the print journal. The Lancet journals are signatories to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors (ICMJE), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE’s guidelines. If your question is not addressed on these pages then the journal’s editorial staff will be pleased to help (+44 [0] 20 7424 4296). Alternatively, email the Editor at david.collingridge@. Author signatures, contribution。

      点击阅读更多内容
      关于金锄头网 - 版权申诉 - 免责声明 - 诚邀英才 - 联系我们
      手机版 | 川公网安备 51140202000112号 | 经营许可证(蜀ICP备13022795号)
      ©2008-2016 by Sichuan Goldhoe Inc. All Rights Reserved.